These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4052933)

  • 1. Hairy cell leukemia. Durability of response to splenectomy in 26 patients and treatment of relapse with androgens in six patients.
    Magee MJ; McKenzie S; Filippa DA; Arlin ZA; Gee TS; Clarkson BD
    Cancer; 1985 Dec; 56(11):2557-62. PubMed ID: 4052933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenectomy for hairy cell leukaemia.
    Ingoldby CJ; Ackroyd N; Catovsky D; Spencer J
    Clin Oncol; 1981 Dec; 7(4):325-31. PubMed ID: 7318275
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term results in hairy cell leukemia treated by splenectomy.
    Chrobák L; Podzimek K; Kerekes Z; Spacek J; Voglová J
    Neoplasma; 1993; 40(2):133-6. PubMed ID: 8350957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical aspects of hairy cell leukemia and its modification by splenectomy].
    Rojo J; Glöckner WM
    Onkologie; 1982 Oct; 5(5):216-21. PubMed ID: 6760022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
    Ehmann WC; Silber R
    Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy for hairy cell leukemia. A clinical review of 63 patients.
    Van Norman AS; Nagorney DM; Martin JK; Phyliky RL; Ilstrup DM
    Cancer; 1986 Feb; 57(3):644-8. PubMed ID: 3943001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic leukapheresis in a patient with hairy cell leukemia presenting with a white cell count greater than 500,000 /microliter.
    Worsley A; Cuttner J; Gordon R; Reilly M; Ambinder EP; Conjalka M
    Transfusion; 1982; 22(4):308-10. PubMed ID: 7101424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
    Moormeier JA; Ratain MJ; Westbrook CA; Vardiman JW; Daly KM; Golomb HM
    J Natl Cancer Inst; 1989 Aug; 81(15):1172-4. PubMed ID: 2746669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparison of two doses of human lymphoblastoid interferon-alpha in hairy cell leukemia. Wellcome HCL Study Group.
    Smalley RV; Anderson SA; Tuttle RL; Connors J; Thurmond LM; Huang A; Castle K; Magers C; Whisnant JK
    Blood; 1991 Dec; 78(12):3133-41. PubMed ID: 1742480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hairy cell leukaemia. Clinical features and effect of splenectomy.
    Jansen J; Hermans J; Remme J; den Ottolander GJ; Cardozo PL
    Scand J Haematol; 1978 Jul; 21(1):60-71. PubMed ID: 694419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement.
    Golomb HM; Vardiman JW
    Blood; 1983 Feb; 61(2):349-52. PubMed ID: 6821700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The history of hairy cell leukemia: characteristics of long-term survivors.
    Bouroncle BA
    Semin Oncol; 1984 Dec; 11(4 Suppl 2):479-85. PubMed ID: 6505709
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemic reticuloendotheliosis: report of a case with peripheral blood remission on androgen therapy.
    Lusch CJ; Ramsey HE; Katayama I
    Cancer; 1978 May; 41(5):1964-6. PubMed ID: 647635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
    Thompson JA; Brady J; Kidd P; Fefer A
    Cancer Treat Rep; 1985; 69(7-8):791-3. PubMed ID: 4016788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of prolonged benefit of initial leukapheresis therapy for hairy cell leukemia.
    Golomb HM; Kraut EH; Oviatt DL; Prendergast EJ; Stein RS; Sweet DL
    Am J Hematol; 1983 Feb; 14(1):49-56. PubMed ID: 6837568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenectomy in hairy cell leukaemia.
    Fitzpatrick M; O'Flanagan F; O'Leary E; Egan E
    Ir Med J; 1987 May; 80(5):145-7. PubMed ID: 3597037
    [No Abstract]   [Full Text] [Related]  

  • 18. Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia.
    Arun B; Curti BD; Longo DL; Stevens D; Alvord WG; Gause BL; Watson T; Kopp WC; Janik JE
    Cancer J Sci Am; 2000; 6(1):21-4. PubMed ID: 10696734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splenectomy for the treatment of hairy-cell leukemia.
    Eldar S; Kemeny MM; Benfield JR
    Surg Gynecol Obstet; 1982 Dec; 155(6):829-32. PubMed ID: 7147163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hairy cell leukemia. A therapeutical update.
    Damasio EE; Pagnucco G; Federico M; Annino L; Chisesi T; Lamparelli T; Lauria F; Castoldi G; Resegotti L
    Haematologica; 1989; 74(2):205-18. PubMed ID: 2473014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.